Uncategorized
VIDEO: Envisia developing drug delivery for glaucoma, retina applications
DENVER — At the Association for Research in Vision and Ophthalmology meeting here, Ben Yerxa, president of Envisia Therapeutics discusses the company’s research into drug delivery for glaucoma and retinal disease treatments.